Etretinate
Etretinate is an oral aromatic retinoid effective in treating psoriasis and various dermatoses. It functions by activating retinoid receptors to promote cell differentiation, suppress proliferation, and reduce inflammatory cell infiltration. This mechanism has been validated in both in vitro cellular assays and in vivo animal models of hyperproliferative skin disorders.
Product Specifications
CAS Number
54350-48-0
Product Name Alternative
Apoptosis, inhibit, Ethyl etrinoate, Etretinate, Etretinato, Inhibitor, Retinoid, Ro 10-9359, Tegison
Field of Research
Cell Biology, Pharmacology & Drug Discovery
Purity
97.89% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:2.5 mg/mL (7.05 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:65 mg/mL (183.37 mM) ; DMSO:65 mg/mL (183.37 mM)
Smiles
CCOC (=O) \C=C (/C) \C=C\C=C (/C) \C=C\c1c (C) cc (OC) c (C) c1C
Molecular Formula
C23H30O3
Molecular Weight
354.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
DPYS (Dihydropyrimidinase, DHP, DHPase, Dihydropyrimidine Amidohydrolase, Hydantoinase) (APC)
DPYS (Dihydropyrimidinase, DHP, DHPase, Dihydropyrimidine Amidohydrolase, Hydantoinase) (APC)
Fatty Acid Binding Protein (FABP) (APC) discontinued
